MLSS Earnings Prediction
The chart below shows how MLSS performed 10 days before and after its earnings report, based on data from the past quarters. Typically, MLSS sees a +6.66% change in stock price 10 days leading up to the earnings, and a -4.62% change 10 days following the report. On the earnings day itself, the stock moves by +1.42%. This data can give you a slight idea of what to expect for the next quarter's release.
MLSS Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
2.51M
22.07%
35.61%
Gross Margin
72.70%
0.64%
-3.92%
Operating Margin
-58.44%
-20.13%
-39.15%
Net Margin
-58.13%
-18.90%
-582.01%
EPS
-0.02
-0.00%
--
No Data Available
MLSS Earnings Analysis
Milestone Scientific, Inc. Common Stock Corporation (MLSS.A) Earnings Conference Call
Positive
Revenue Surge in Dental Division: The company achieved a 22% increase in year-over-year revenue, reaching $2.5 million, primarily driven by strong growth in the dental division, particularly international dental sales which increased by 57%.
E-commerce Gross Margin Strength: The shift to an e-commerce sales model has strengthened gross margins, which remain high at 73%.
Compuflo Epidural System Progress: The medical division continues to see substantial progress rolling out the Compuflo Epidural System, which offers real-time pressure feedback to assist physicians with precise needle placement and verification.
Gross Profit Increase: The company recorded gross profit for the third quarter ended September 30, 2024, of $1.8 million or 73% of revenue, compared to $1.5 million and 73% of revenue for the third quarter ending September 30, 2023, indicating an increase in gross profit due to higher international sales.
Strong Financial Position: The company maintained a solid balance sheet with approximately $4.8 million of cash and cash equivalents as of September 30, 2024, providing sufficient resources to support growth within both the dental and medical divisions.
Negative
Revenue Decline Analysis: Revenue for the three months ending September 30, 2024 and 2023 was approximately $2.5 million and $2.1 million respectively, indicating a decline in revenue growth.
China Revenue Decline: The company recorded no revenue from China for the three months ending September 30, 2024 compared to approximately $270,000 for the nine months ending September 30, 2023.
Operating Loss Decrease: Operating loss for the three months ending September 30, 2024 was approximately $1.5 million, a decrease of approximately $38,000 compared to the previous year.
Net Loss Comparison: Net loss was approximately $1.5 million, or $0.02 per share for the three months ending September 30, 2024, compared to a net loss of $5 million and $0.07 per share for the comparable period in 2023.
Gross Profit Comparison: The gross profit for the first nine months of 2024 was $4.9 million, or 74% of revenue, versus $5.3 million, or 70% of revenue for the first nine months of 2023.
MLSS FAQs
How does MLSS typically perform around its earnings report dates?
Is Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
MLSS Earning Call Sentiment
Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
MLSS.A
0.84%Positive
The earnings call summary highlights a 22% YoY revenue increase, improved operational efficiency, and strong growth in the dental division. The Q&A section reveals a new partnership with Axial Biologics, which is a positive catalyst. Despite some risks and uncertainties, the company's strong balance sheet and commitment to shareholder value are favorable. Overall, the positive financial performance, strategic partnerships, and operational improvements suggest a positive stock price movement over the next two weeks.
